# Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma

> **NCT00878995** · PHASE1 · COMPLETED · sponsor: **The University of Texas Medical Branch, Galveston** · enrollment: 28 (actual)

## Conditions studied

- Cachexia
- Squamous Cell Carcinoma

## Interventions

- **DRUG:** Placebo Testosterone
- **DRUG:** Testosterone Enanthate 100 MG/ML

## Key facts

- **NCT ID:** NCT00878995
- **Lead sponsor:** The University of Texas Medical Branch, Galveston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06-03
- **Primary completion:** 2014-06
- **Final completion:** 2015-06
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-03-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00878995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00878995, "Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00878995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*